Please use this identifier to cite or link to this item:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Biofilm matrix exoproteins induce a protective immune response against Staphylococcus aureus biofilm infection

AuthorsGil, Carmen; Solano Goñi, Cristina CSIC ORCID; Burgui, Saioa; Latasa Osta, Cristina CSIC; García, Begoña CSIC ORCID; Toledo-Arana, Alejandro CSIC ORCID ; Lasa, Íñigo CSIC ORCID; Valle Turrillas, Jaione CSIC ORCID
Issue Date16-Dec-2013
PublisherAmerican Society for Microbiology
CitationInfection and Immunity 82(3): 1017-1029 (2014)
AbstractThe Staphylococcus aureus biofilm mode of growth is associated with several chronic infections that are very difficult to treat due to the recalcitrant nature of biofilms to clearance by antimicrobials. Accordingly, there is an increasing interest in preventing the formation of S. aureus biofilms and developing efficient antibiofilm vaccines. Given the fact that during a biofilm-associated infection, the first primary interface between the host and the bacteria is the self-produced extracellular matrix, in this study we analyzed the potential of extracellular proteins found in the biofilm matrix to induce a protective immune response against S. aureus infections. By using proteomic approaches, we characterized the exoproteomes of exopolysaccharide-based and proteinbased biofilm matrices produced by two clinical S. aureus strains. Remarkably, results showed that independently of the nature of the biofilm matrix, a common core of secreted proteins is contained in both types of exoproteomes. Intradermal administration of an exoproteome extract of an exopolysaccharide-dependent biofilm induced a humoral immune response and elicited the production of interleukin 10 (IL-10) and IL-17 in mice. Antibodies against such an extract promoted opsonophagocytosis and killing of S. aureus. Immunization with the biofilm matrix exoproteome significantly reduced the number of bacterial cells inside a biofilm and on the surrounding tissue, using an in vivo model of mesh-associated biofilm infection. Furthermore, immunized mice also showed limited organ colonization by bacteria released from the matrix at the dispersive stage of the biofilm cycle. Altogether, these data illustrate the potential of biofilm matrix exoproteins as a promising candidate multivalent vaccine against S. aureus biofilm-associated infections. © 2014, American Society for Microbiology.
Publisher version (URL)
Identifiersissn: 0019-9567
e-issn: 1098-5522
Appears in Collections:(IDAB) Artículos

Files in This Item:
File Description SizeFormat
Biofilm matrix exoproteins_Gil.pdf2,08 MBAdobe PDFThumbnail
Show full item record
Review this work

PubMed Central

checked on Jan 12, 2022


checked on Jan 20, 2022


checked on Jan 21, 2022

Page view(s)

checked on Jan 23, 2022


checked on Jan 23, 2022

Google ScholarTM




Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.